FDA Import Refusal FP1-0021113-4/161/1 — GlaxoSmithKline Biologicals SA
The FDA refused shipment FP1-0021113-4/161/1 from GlaxoSmithKline Biologicals SA (Belgium) on March 9, 2018. The refused product falls under Drugs and Biologics — VARICELLA VIRUS VACCINE. Cited charge: 71 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 9, 2018
- Country
- Belgium
- Product Category
- Drugs and Biologics
- Product Code
- 57CH29 VARICELLA VIRUS VACCINE
- Charges
- 71